Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125753301 | 12575330 | 1 | I | 2013 | 20160517 | 20160720 | 20160720 | EXP | AU-AMGEN-AUSSP2016064104 | AMGEN | 61.00 | YR | A | F | Y | 0.00000 | 20160720 | MD | AU | AU |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125753301 | 12575330 | 1 | PS | PROLIA | DENOSUMAB | 1 | Subcutaneous | 60 MG, UNK | Y | 125320 | 60 | MG | SOLUTION FOR INJECTION | ||||||
| 125753301 | 12575330 | 2 | C | AVAPRO | IRBESARTAN | 1 | 300 MG, QD | 0 | 300 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125753301 | 12575330 | 1 | Osteoporosis postmenopausal |
| 125753301 | 12575330 | 2 | Hypertension |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125753301 | 12575330 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125753301 | 12575330 | Influenza like illness | |
| 125753301 | 12575330 | Malaise | |
| 125753301 | 12575330 | Pain |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125753301 | 12575330 | 1 | 20130530 | 20130530 | 0 | |
| 125753301 | 12575330 | 2 | 2006 | 0 |